Runkai Li
About Runkai Li
Runkai Li serves as the Director of Analytical Development at Mirati Therapeutics, where he has worked since 2021. He has extensive experience in analytical chemistry, having previously held positions at Bristol-Myers Squibb, Allergan, Celgene, and Labstat International.
Current Role at Mirati Therapeutics
Runkai Li serves as the Director of Analytical Development, CMC at Mirati Therapeutics, a position held since 2021. In this role, he is responsible for overseeing the analytical development budget and managing global CRO/CMO activities. His leadership has been pivotal in advancing the analytical development of Adagrasib (MRTX849), a KRASG12C inhibitor, which is a significant focus of the company's therapeutic pipeline. His work contributes to the overall mission of Mirati Therapeutics in developing innovative cancer therapies.
Previous Experience at Bristol-Myers Squibb
Before joining Mirati Therapeutics, Runkai Li worked at Bristol-Myers Squibb as a Senior Principal Scientist and Analytical Technical Lead from 2017 to 2021. During his four years at the Summit, NJ location, he played a critical role in analytical development projects, contributing to the company's research and development efforts in the pharmaceutical sector.
Experience at Allergan
Runkai Li was employed at Allergan as a Senior Scientist and Analytical CMC Lead from 2010 to 2017. His seven-year tenure in Irvine, CA, involved leading analytical development initiatives and ensuring compliance with CMC requirements. His expertise in analytical chemistry was instrumental in supporting the company's product development goals.
Educational Background in Chemistry
Runkai Li has a strong academic foundation in chemistry. He earned a PhD in Analytical Chemistry from Queen's University. Prior to that, he completed both a Bachelor of Science in Chemistry and a Master of Science in Analytical Chemistry at Peking University. This extensive educational background has equipped him with the knowledge and skills necessary for his roles in analytical development.
Career Development at Celgene and Labstat International
Runkai Li also held positions at Celgene and Labstat International ULC. At Celgene, he served as a Principal Scientist and Analytical Technical Lead from 2017 to 2019, where he contributed to analytical development efforts. Earlier in his career, he worked as a Scientist at Labstat International ULC from 2007 to 2010, gaining valuable experience in the field of analytical chemistry.